AXL induced TANK binding kinase 1 (TBK1)-NF-κB signaling pathway and innate immune suppression in the TME in pancreatic cancer (73), while inhibition of AXL with small molecule R428 enhanced immune stimulatory microenvironment (73). This evidence concerns the gene AXL and pancreatic neoplasm.